AdaptHealth Corp. (NASDAQ:AHCO) Short Interest Up 11.2% in February

AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 9,540,000 shares, an increase of 11.2% from the February 13th total of 8,580,000 shares. Based on an average daily trading volume, of 955,200 shares, the short-interest ratio is presently 10.0 days. Approximately 13.1% of the shares of the stock are short sold.

Insider Transactions at AdaptHealth

In related news, major shareholder Everest Hill Group Inc. sold 340,000 shares of the business’s stock in a transaction on Thursday, January 12th. The stock was sold at an average price of $20.00, for a total value of $6,800,000.00. Following the sale, the insider now owns 13,459,998 shares of the company’s stock, valued at approximately $269,199,960. The sale was disclosed in a legal filing with the SEC, which is available through this link. In the last ninety days, insiders sold 1,140,000 shares of company stock valued at $23,269,789. Corporate insiders own 17.29% of the company’s stock.

Institutional Trading of AdaptHealth

Several hedge funds have recently modified their holdings of the stock. Versant Capital Management Inc bought a new position in AdaptHealth in the 3rd quarter worth approximately $26,000. Group One Trading L.P. increased its stake in shares of AdaptHealth by 134.3% in the 1st quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock valued at $60,000 after buying an additional 2,132 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of AdaptHealth by 49.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,675 shares of the company’s stock valued at $71,000 after buying an additional 1,209 shares during the period. Point72 Hong Kong Ltd bought a new stake in shares of AdaptHealth during the first quarter worth $82,000. Finally, Tower Research Capital LLC TRC lifted its stake in shares of AdaptHealth by 49.0% during the third quarter. Tower Research Capital LLC TRC now owns 4,957 shares of the company’s stock valued at $93,000 after acquiring an additional 1,630 shares during the period. 86.33% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. SVB Securities cut their price target on shares of AdaptHealth from $30.00 to $23.00 in a report on Wednesday, March 1st. Robert W. Baird cut their target price on shares of AdaptHealth from $31.00 to $23.00 and set an “outperform” rating for the company in a research note on Wednesday, March 1st. Finally, Truist Financial decreased their price target on AdaptHealth from $28.00 to $20.00 in a research report on Wednesday, March 1st. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $25.33.

AdaptHealth Trading Up 0.8 %

AHCO opened at $13.27 on Wednesday. AdaptHealth has a 1-year low of $11.40 and a 1-year high of $27.48. The stock has a market capitalization of $1.79 billion, a PE ratio of 51.04, a PEG ratio of 0.61 and a beta of 0.71. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.00. The firm has a 50-day moving average price of $19.78 and a two-hundred day moving average price of $20.28.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.